massive post operative hemorrhage in PACU with AKI and hypovolemic schock - Nursing Case Study

Pathophysiology

• Primary mechanism: Massive post-operative hemorrhage leads to significant blood loss, resulting in decreased circulating blood volume and reduced oxygen delivery to tissues, causing hypovolemic shock.

• Secondary mechanism: The body's compensatory mechanisms, such as vasoconstriction and increased heart rate, are overwhelmed, leading to inadequate perfusion of the kidneys and subsequent acute kidney injury (AKI) due to ischemia.

• Key complication: Hypovolemic shock exacerbates AKI by further reducing renal perfusion, potentially leading to multi-organ failure if not promptly managed with fluid resuscitation and blood transfusions.

Patient Profile

Demographics:

55-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Previous abdominal surgery

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and dizziness

• Key symptoms: Excessive bleeding from surgical site, decreased urine output, confusion, weakness

• Vital signs: Blood pressure 85/50 mmHg, heart rate 122 bpm, respiratory rate 24 breaths per minute, temperature 99.1°F, SpO2 92% on room air

Section 1

As the patient is monitored in the Post Anesthesia Care Unit (PACU), his condition begins to deteriorate despite initial interventions. The medical team has initiated fluid resuscitation with crystalloids and blood transfusions to address the hypovolemic shock, yet his vital signs remain unstable. His blood pressure continues to hover around 85/50 mmHg, and his heart rate has increased to 130 bpm, indicating ongoing circulatory compromise. Moreover, his respiratory rate has risen to 28 breaths per minute, and his oxygen saturation has dropped to 89% on room air, suggesting a need for supplemental oxygen to support tissue oxygenation.

New diagnostic results present concerning findings. A repeat complete blood count shows a hemoglobin level that has decreased to 6.8 g/dL, confirming significant blood loss. Additionally, serum creatinine levels have spiked to 2.5 mg/dL from a baseline of 1.1 mg/dL, corroborating the development of acute kidney injury. Arterial blood gas analysis reveals metabolic acidosis with a pH of 7.28, indicating inadequate perfusion and oxygen delivery at the cellular level. These lab results underscore the urgency of the situation and the need for aggressive intervention.

The medical team adjusts the patient's care plan to address these new complications. They increase the rate of blood transfusions and initiate vasopressor support to stabilize blood pressure and improve perfusion. Furthermore, the patient is placed on high-flow oxygen to enhance oxygen delivery. As the team considers these interventions, they also discuss the potential need for renal replacement therapy should the patient's renal function continue to decline. The evolving clinical picture requires careful re-evaluation and adjustment of the treatment strategy, emphasizing the importance of ongoing monitoring and timely interventions to prevent further deterioration and potential multi-organ failure.

Section 2

As the medical team closely monitors the patient in the PACU, they observe a change in his status that suggests the emergence of new complications. Despite the increased rate of blood transfusions and initiation of vasopressor support, the patient's blood pressure remains tenuous at 90/55 mmHg, and his heart rate continues to be tachycardic at 125 bpm. His respiratory rate has increased further to 32 breaths per minute, and his oxygen saturation, even on high-flow oxygen, has only marginally improved to 92%. Clinicians are concerned about the possibility of ongoing internal bleeding or coagulopathy, given the patient's unresponsive hemodynamic state and decreased hemoglobin levels.

Simultaneously, the patient's urine output has dwindled to less than 20 mL/hour, a stark indication of worsening acute kidney injury. Repeat laboratory tests show a further increase in serum creatinine to 3.0 mg/dL and a blood urea nitrogen (BUN) level that has risen to 45 mg/dL, reinforcing the gravity of renal dysfunction. The arterial blood gas analysis reveals persistent metabolic acidosis with a pH of 7.25 and an elevated lactate level of 4.5 mmol/L, suggesting inadequate tissue perfusion and potential systemic involvement.

In response to these developments, the team deliberates on the necessity of further diagnostic imaging to identify possible sources of ongoing bleeding or complications such as abdominal compartment syndrome. They also discuss the initiation of renal replacement therapy to manage the acute kidney injury and prevent further metabolic derangement. The multidisciplinary team remains vigilant, acknowledging the complexity of the patient's condition and the critical need for an adaptive, comprehensive approach to stabilize and support his recovery trajectory.

Section 3

As the medical team proceeds with their adaptive management plan, they decide to prioritize further diagnostic imaging to identify potential sources of ongoing bleeding or complications such as abdominal compartment syndrome. A stat CT scan of the abdomen and pelvis is obtained, revealing a significant hematoma in the retroperitoneal space, suggestive of continued postoperative hemorrhage. This finding prompts an urgent surgical consult to evaluate the need for exploratory surgery to control the bleeding source. Concurrently, the team acknowledges the risk of worsening coagulopathy, potentially exacerbated by the dilutional effect of massive transfusion and the patient's underlying critical state.

In parallel, the patient's renal function continues to decline, evidenced by the latest laboratory results showing an even higher serum creatinine of 3.5 mg/dL and a BUN level climbing to 55 mg/dL. The patient's metabolic acidosis and elevated lactate levels remain concerning, indicating ongoing tissue hypoperfusion and metabolic stress. In light of these findings, the nephrology team is consulted, and they agree on the initiation of continuous renal replacement therapy (CRRT) to manage the acute kidney injury and address the acid-base imbalance, aiming to stabilize the patient's metabolic state and prevent further complications.

The team remains acutely aware of the interrelated nature of the patient's conditions, recognizing that effective management requires a dynamic and coordinated approach. They focus on closely monitoring the patient's hemodynamics, adjusting vasopressor support as needed, and continuously evaluating the effectiveness of interventions. This integrated strategy ensures that the team remains agile in their response, prepared to address any new developments in the patient's complex clinical picture.

Section 4

As the surgical team prepares for possible intervention, the patient's condition presents new challenges. During the reassessment in the PACU, the patient's vital signs show a blood pressure of 85/50 mmHg, heart rate of 120 beats per minute, and respiratory rate of 24 breaths per minute, indicating persistent hemodynamic instability despite ongoing fluid resuscitation and vasopressor support. The patient's skin remains cool and clammy, with capillary refill time exceeding four seconds, further corroborating the state of hypoperfusion.

The latest laboratory results reveal a significant drop in hemoglobin to 7.8 g/dL, underscoring the urgency of managing the retroperitoneal hematoma. Coagulation parameters are also concerning, with an international normalized ratio (INR) of 2.5 and a platelet count of 90,000/mm³, suggesting a coagulopathic state. These findings prompt the team to initiate a targeted transfusion protocol, including fresh frozen plasma and platelets, to correct the coagulopathy and support hemostasis.

While preparing for potential surgical intervention, the team also notes a change in the patient's neurological status. The patient becomes increasingly lethargic, with a Glasgow Coma Scale score dropping to 11, indicating the risk of further deterioration. This development emphasizes the need for a multidisciplinary approach, coordinating with neurology and critical care teams to explore potential causes, such as cerebral hypoperfusion or metabolic encephalopathy. The team remains vigilant, understanding that timely intervention and continuous reevaluation are crucial to optimizing outcomes and preventing further complications in this complex clinical scenario.

Section 5

As the team continues to manage the patient's condition, they notice further alterations in the patient's respiratory status. The patient's oxygen saturation begins to decline, dropping to 88% on a high-flow nasal cannula set at 60% oxygen. Auscultation reveals diminished breath sounds bilaterally with fine crackles at the bases, suggesting potential fluid overload due to aggressive fluid resuscitation. A chest X-ray is promptly ordered, revealing bilateral pulmonary edema, indicative of acute respiratory distress syndrome (ARDS) secondary to the massive transfusion and ongoing inflammatory response.

In response to these findings, the team initiates non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce the work of breathing. They also adjust the fluid management strategy, opting for a more conservative approach to limit further pulmonary complications. Diuretics are cautiously introduced to facilitate fluid removal while monitoring renal function closely, given the patient's existing acute kidney injury (AKI). Follow-up arterial blood gas analysis shows a pH of 7.32, a PaCO2 of 48 mmHg, and a PaO2 of 62 mmHg, confirming respiratory acidosis and the need for continued respiratory support and optimization of ventilation strategies.

The patient's condition underscores the intricate balance required in managing complex cases where multiple systems are compromised. The multidisciplinary team remains alert to the possibility of additional complications, such as worsening renal function or further neurological decline. They schedule a series of follow-up evaluations, including repeat imaging and laboratory tests, to closely monitor the patient's response to the adjusted treatment plan. This vigilant approach ensures timely modifications to interventions, aiming to stabilize the patient and prevent the progression of multi-organ dysfunction.